Topical tacrolimus for treatment of atopic dermatitis.
D000287:Administration, Topical; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D011537:Pruritus / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology
D016559:Tacrolimus